Russell J. Garland

Minimal Residual Disease Status Before Allogeneic Bone Marrow Transplantation Is an Important Determinant of Successful Outcome for Children and Adolescents With Acute Lymphoblastic Leukemia

C. Knechtli, Nicholas J. Goulden, Jeremy Hancock et al. · Blood · 1998 · 256 citations

Signalling of DNA damage and cytokines across cell barriers exposed to nanoparticles depends on barrier thickness

Anubhuti Sood, Saif Salih, Danny S. Roh et al. · Nature Nanotechnology · 2011 · 123 citations

Nanoparticles, Dna Nanotechnology, Nanoparticles Depends +10

Minimal residula disease status as a predictor of relapse after allogenic bone marrow transplantation for children with acute lymphoblastic leukaemia

C. Knechtli, Nicholas J. Goulden, Jeremy Hancock et al. · British Journal of Haematology · 1998 · 111 citations

Tcrgamma Gene Rearrangements, Immunology, Pathology +17

Minimal residual disease analysis for the prediction of relapse in children with standard‐risk acute lymphoblastic leukaemia

Nicholas J. Goulden, C. Knechtli, Russell J. Garland et al. · British Journal of Haematology · 1998 · 101 citations · Full text

Functional analysis of the CD8⁺CD57⁺ cell population in normal healthy individuals and matched unrelated T‐cell‐depleted bone marrow transplant recipients

Anthony W. Rowbottom, Russell J. Garland, Markus Lepper et al. · British Journal of Haematology · 2000 · 18 citations